Oncotarget

Research Papers:

Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells

Ping Song _, Li Ye, Jiajun Fan, Yubin Li, Xian Zeng, Ziyu Wang, Shaofei Wang, Guoping Zhang, Ping Yang, Zhonglian Cao and Dianwen Ju

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:3861-3873. https://doi.org/10.18632/oncotarget.2869

Metrics: PDF 1950 views  |   HTML 1776 views  |   ?  


Abstract

Ping Song1,*, Li Ye1,*, Jiajun Fan1, Yubin Li1, Xian Zeng1, Ziyu Wang1, Shaofei Wang1, Guoping Zhang2, Ping Yang3, Zhonglian Cao3, Dianwen Ju1

1Department of Biosynthesis & The Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, 201203, P.R. China

2Institute of Biomedical Science, Fudan University, Shanghai, 200032, P.R. China

3Instrumental Analysis Center, School of Pharmacy, Fudan University, Shanghai, 201203, P.R. China

*These authors have contributed equally to this work

Correspondence to:

Dianwen Ju, e-mail: dianwenju@fudan.edu.cn

Keywords: asparaginase, autophagy, apoptosis, chronic myeloid leukemia

Received: July 26, 2014     Accepted: December 07, 2014     Published: January 08, 2015

ABSTRACT

The antitumor enzyme asparaginase, which targets essential amino acid L-asparagine and catalyzes it to L-aspartic acid and ammonia, has been used for years in the treatment of acute lymphoblastic leukemia (ALL), subtypes of myeloid leukemia and T-cell lymphomas, whereas the anti-chronic myeloid leukemia (CML) effect of asparaginase and its underlying mechanism has not been completely elucidated. We have shown here that asparaginase induced significant growth inhibition and apoptosis in K562 and KU812 cells. Apart from induction of apoptosis, we reported for the first time that asparaginase induced autophagic response in K562 and KU812 cells as evidenced by the formation of autophagosome, microtubule-associated protein light chain 3 (LC3)-positive autophagy-like vacuoles, and the upregulation of LC3-II. Further study suggested that the Akt/mTOR (mammalian target of rapamycin) and Erk (extracellular signal-regulated kinase) signaling pathway were involved in asparaginase-induced autophagy in K562 cells. Moreover, blocking autophagy using pharmacological inhibitors LY294002, chloroquine (CQ) and quinacrine (QN) enhanced asparaginase-induced cell death and apoptosis, indicating the cytoprotective role of autophagy in asparaginase-treated K562 and KU812 cells. Together, these findings provide a rationale that combination of asparaginase anticancer activity and autophagic inhibition might be a promising new therapeutic strategy for CML.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 2869